快速审查方法系列:关于快速定性证据综合的指导
Andrew Booth1,2, Isolde Sommer3,4, Jane Noyes2,5
1EnSyGN Sheffield Evidence Synthesis Group, University of Sheffield, Sheffield, UK a.booth@sheffield.ac.uk.
BMJ evidence-based medicine
|February 14, 2024
概括
本指南提供了快速定性证据综合 (QES) 的方法,以加快资源限制下的研究综合. 它详细介绍了有效的研究选择,数据提取和质量评估的策略,以便及时审查.
科学领域:
- 健康研究方法 健康研究方法
- 证据综合 证据综合
- 定性研究是指质量研究.
背景情况:
- 资源限制需要加速证据综合方法.
- 定性证据综合 (QES) 需要修改系统方法.
- 科克伦快速审查方法小组提供方法指导.
研究的目的:
- 为快速进行定性证据综合 (QES) 提供指导.
- 概述在资源限制下加速定性证据合成的方法.
- 详细说明快速QES的审查过程.
主要方法:
- 使用修改后的系统,透明和可重复的QES方法.
- 采用模板和有针对性的知识用户参与.
- 定义视角,管理间接证据,抽样,并利用现有的QES.
主要成果:
- 信息专家对于数据库优先级和搜索策略是非常宝贵的.
- 模板和框架有助于研究选择和数据提取.
- 质量保证程序和适当的综合方法 (主题,框架) 提高效率.
结论:
- 通过战略规划和方法调整,可以实现快速QES.
- 建议使用GRADE等工具来评估对定性证据的信心.
- 通过明智地应用这些方法,可以获得及时和有用的审查产品.
相关概念视频
RACE - Rapid Amplification of cDNA Ends
6.3K
Rapid Amplification of cDNA Ends, or RACE, is one of the most effective methods to obtain a full-length cDNA from an mRNA sequence between a known internal region to the unknown sequence at the 5’ or 3’ end. The unknown region is cloned in the cDNA by a gene-specific primer that binds the known end, and a hybrid primer that attaches a predefined anchor sequence to the unknown end of the cDNA. The sequence in between is amplified by PCR with an anchor primer and a gene-specific...
6.3K
Cochran's Q Test
330
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
330
Hazard Ratio
122
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
122
Real Time RT-PCR
57.3K
Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
The real-time quantification of the number of amplified products is...
57.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
126
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
126


